(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OZEMPIC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OZEMPIC

ST13

US500000079414842

Class

5

Filing

79414842

Registration

8112811

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

08/05/2026

Trademark type

Combined

Nice classes

5

Filing date

08/28/2024

Registration date

01/27/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/27/2026

Last transaction

08/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

DK

Examiner

HANNAH, JESSICA L

Law office

L40

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized word "OZEMPIC" in red and orange gradient, with the bottom left portion of the mark being red and transitioning to orange in the top right portion of the mark.

Holders and representatives

Holders

Novo Nordisk A/S

Representatives

Emily J Barnhart

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of diabetes.

Publications

History of USPTO decisions and trademark events.

27 publications found

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/05/2026

FIMP

FINAL DISPOSITION PROCESSED

08/05/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

07/02/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

06/15/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

06/15/2026

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/27/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/27/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

01/27/2026

GPNX

NOTIFICATION PROCESSED BY IB

12/11/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/09/2025

PUBO

PUBLISHED FOR OPPOSITION

12/09/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/03/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/26/2025

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/25/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/10/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/07/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/07/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/07/2025

RFNT

REFUSAL PROCESSED BY IB

05/31/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/14/2025

RFRR

REFUSAL PROCESSED BY MPU

05/13/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/22/2025

CNRT

NON-FINAL ACTION WRITTEN

03/21/2025

DOCK

ASSIGNED TO EXAMINER

03/04/2025

MAFR

APPLICATION FILING RECEIPT MAILED

01/17/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/17/2025

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/16/2025

Continuous trademark protection

Get notified about every new filing that threatens OZEMPIC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.